1. A low dose of a new proton pump inhibitor LY307640 (E3810) effectively inhibits acid secretion in humans;Kovacs;Gastroenterology,1996
2. The effects of rabeprazole on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects;Blanshard;Gut,1996
3. Rabeprazole effectively inhibits 24-hour H+ activity and nocturnal acid secretion in healthy subjects;Dammann;Gut,1996
4. Rabeprazole in treatment of acid peptic diseases: Results of three placebo-controlled dose-response trials in duodenal ulcer, gastric ulcer and gastroesophageal reflux disease (GERD;Cloud;Dig Dis Sci,1998
5. Drug-drug interaction evaluation of rabeprazole sodium: a clean/expected slate?;Humphries;Gut,1996